Alejandro Villagra

5.4k total citations
65 papers, 4.0k citations indexed

About

Alejandro Villagra is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Alejandro Villagra has authored 65 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 27 papers in Oncology and 21 papers in Immunology. Recurrent topics in Alejandro Villagra's work include Histone Deacetylase Inhibitors Research (42 papers), Protein Degradation and Inhibitors (20 papers) and Peptidase Inhibition and Analysis (19 papers). Alejandro Villagra is often cited by papers focused on Histone Deacetylase Inhibitors Research (42 papers), Protein Degradation and Inhibitors (20 papers) and Peptidase Inhibition and Analysis (19 papers). Alejandro Villagra collaborates with scholars based in United States, Chile and Czechia. Alejandro Villagra's co-authors include Eduardo M. Sotomayor, Edward Seto, Fengdong Cheng, David Woods, Karrune Woan, Jeffrey S. Weber, Javier Pinilla‐Ibarz, Andressa L. Sodré, Alan P. Kozikowski and Amod A. Sarnaik and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular Cell.

In The Last Decade

Alejandro Villagra

62 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alejandro Villagra United States	34	2.9k	1.4k	1.1k	414	219	65	4.0k
Wayne Pearce United Kingdom	24	2.1k 0.7×	808 0.6×	1.6k 1.4×	223 0.5×	294 1.3×	30	3.7k
Maribel González‐García United States	9	2.7k 0.9×	802 0.6×	942 0.8×	423 1.0×	197 0.9×	15	3.7k
Nicolas van Baren Belgium	32	2.1k 0.7×	2.3k 1.6×	2.9k 2.6×	341 0.8×	209 1.0×	54	4.9k
Kian‐Huat Lim United States	29	2.4k 0.8×	1.6k 1.1×	781 0.7×	752 1.8×	257 1.2×	97	4.2k
Russell W. Jenkins United States	28	2.0k 0.7×	1.2k 0.8×	1.0k 0.9×	303 0.7×	151 0.7×	57	3.5k
Pilar Navarro Spain	33	2.6k 0.9×	979 0.7×	914 0.8×	593 1.4×	180 0.8×	80	4.1k
Ruth W. Craig United States	29	2.3k 0.8×	965 0.7×	734 0.7×	452 1.1×	241 1.1×	44	3.3k
Lisa M. Minter United States	27	1.6k 0.6×	563 0.4×	1.0k 0.9×	430 1.0×	104 0.5×	65	2.9k
Takeshi Senga Japan	37	2.8k 1.0×	957 0.7×	540 0.5×	712 1.7×	161 0.7×	113	4.1k
Roland P. Piekorz Germany	33	1.6k 0.6×	1.0k 0.7×	1.1k 1.0×	396 1.0×	223 1.0×	75	3.4k

Countries citing papers authored by Alejandro Villagra

Since Specialization

Citations

This map shows the geographic impact of Alejandro Villagra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Villagra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Villagra more than expected).

Fields of papers citing papers by Alejandro Villagra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Villagra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Villagra. The network helps show where Alejandro Villagra may publish in the future.

Co-authorship network of co-authors of Alejandro Villagra

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Villagra. A scholar is included among the top collaborators of Alejandro Villagra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Villagra. Alejandro Villagra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gracia-Hernandez, Maria, Abootaleb Sedighi, Mulu Geletu, et al.. (2025). Improved Pharmacokinetic Profiles of HDAC6 Inhibitors via Cap Group Modifications. Journal of Medicinal Chemistry. 68(17). 18216–18229.

Mardones, Claudia, et al.. (2023). Role of HDAC6-STAT3 in immunomodulatory pathways in Colorectal cancer cells. Molecular Immunology. 164. 98–111. 4 indexed citations

Noonepalle, Satish, Scott Grindrod, Nima Aghdam, et al.. (2023). Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 Inhibition. Molecular Cancer Therapeutics. 22(12). 1376–1389. 11 indexed citations

Gomez, Stephanie, Melissa Hadley, Elisa Arthofer, et al.. (2022). Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer. Journal for ImmunoTherapy of Cancer. 10(11). e004974–e004974. 24 indexed citations

Cheema, Amrita K., Yaoxiang Li, Keith Kowalczyk, et al.. (2022). Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate Cancers. Clinical Cancer Research. 29(5). 921–929. 8 indexed citations

Gracia-Hernandez, Maria, et al.. (2021). Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers. Cancers. 13(24). 6180–6180. 14 indexed citations

Lin, Jianqing, Erica Palmer, Christian Zevallos‐Delgado, et al.. (2021). Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer. The Oncologist. 26(12). e2136–e2142. 12 indexed citations

Banik, Debarati, Satish Noonepalle, Melissa Hadley, et al.. (2020). HDAC6 Plays a Noncanonical Role in the Regulation of Antitumor Immune Responses, Dissemination, and Invasiveness of Breast Cancer. Cancer Research. 80(17). 3649–3662. 50 indexed citations

Cano‐Mejia, Juliana, et al.. (2020). CpG-coated prussian blue nanoparticles-based photothermal therapy combined with anti-CTLA-4 immune checkpoint blockade triggers a robust abscopal effect against neuroblastoma. Translational Oncology. 13(10). 100823–100823. 45 indexed citations

10.

Hadley, Melissa, Satish Noonepalle, Debarati Banik, & Alejandro Villagra. (2019). Functional Analysis of HDACs in Tumorigenesis. Methods in molecular biology. 1983. 279–307. 16 indexed citations

11.

Powers, John J., Maritza Lienlaf, Patricio Perez-Villarroel, et al.. (2016). Expression and Function of Histone Deacetylase 10 (HDAC10) in B Cell Malignancies. Methods in molecular biology. 1436. 129–145. 6 indexed citations

12.

Lienlaf, Maritza, Patricio Perez-Villarroel, Tessa Knox, et al.. (2016). Essential role of HDAC6 in the regulation of PD‐L1 in melanoma. Molecular Oncology. 10(5). 735–750. 136 indexed citations

13.

Woods, David, Andressa L. Sodré, Alejandro Villagra, et al.. (2015). HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade. Cancer Immunology Research. 3(12). 1375–1385. 348 indexed citations

14.

Paraiso, Kim H.T., Meghna Das Thakur, Bin Fang, et al.. (2014). Ligand-Independent EPHA2 Signaling Drives the Adoption of a Targeted Therapy–Mediated Metastatic Melanoma Phenotype. Cancer Discovery. 5(3). 264–273. 85 indexed citations

15.

Kizuka, Yasuhiko, et al.. (2014). Epigenetic Regulation of a Brain-specific Glycosyltransferase N-Acetylglucosaminyltransferase-IX (GnT-IX) by Specific Chromatin Modifiers. Journal of Biological Chemistry. 289(16). 11253–11261. 38 indexed citations

16.

Woods, David, Karrune Woan, Fengdong Cheng, et al.. (2013). The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity. Melanoma Research. 23(5). 341–348. 81 indexed citations

17.

Cheng, Fengdong, Hongwei Wang, Pedro Horna, et al.. (2012). Stat3 Inhibition Augments the Immunogenicity of B-cell Lymphoma Cells, Leading to Effective Antitumor Immunity. Cancer Research. 72(17). 4440–4448. 15 indexed citations

18.

Yuan, Zhigang, Alejandro Villagra, Lirong Peng, et al.. (2010). The ATDC (TRIM29) Protein Binds p53 and Antagonizes p53-Mediated Functions. Molecular and Cellular Biology. 30(12). 3004–3015. 95 indexed citations

19.

Yarde, Danielle N., Vasco Oliveira, Linda Mathews, et al.. (2009). Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma. Cancer Research. 69(24). 9367–9375. 90 indexed citations

20.

Sengupta, Nilanjan, et al.. (2006). Histone Deacetylase 8 Safeguards the Human Ever-Shorter Telomeres 1B (hEST1B) Protein from Ubiquitin-Mediated Degradation. Molecular and Cellular Biology. 26(19). 7342–7342. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact